Paratek Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PRTK and buy or sell other stocks, ETFs, and their options commission-free!About PRTK
Paratek Pharmaceuticals, Inc. engages in the development and commercialization of therapies based upon tetracycline chemistry. Its products include omadacycline and sarecycline, which are used for the treatment of community-acquired bacterial infections, including community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections and urinary tract infections.
CEOEvan Loh, MD
CEOEvan Loh, MD
Employees—
Employees—
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded1996
Founded1996
Employees—
Employees—
PRTK Key Statistics
Market cap127.83M
Market cap127.83M
Price-Earnings ratio-2.00
Price-Earnings ratio-2.00
Dividend yield—
Dividend yield—
Average volume1.55M
Average volume1.55M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.65
52 Week high$3.65
52 Week low$1.29
52 Week low$1.29
Stock Snapshot
The current Paratek Pharmaceuticals(PRTK) stock price is $2.23, with a market capitalization of 127.83M. The stock trades at a price-to-earnings (P/E) ratio of -2.00.
Paratek Pharmaceuticals(PRTK) stock opened on 2025-12-15 at —. The price climbed to — and dipped to —.
Paratek Pharmaceuticals(PRTK) shares are trading with a volume of 0, against a daily average of 1.55M.
During the past year, Paratek Pharmaceuticals(PRTK) stock moved between $1.29 at its lowest and $3.65 at its peak.
During the past year, Paratek Pharmaceuticals(PRTK) stock moved between $1.29 at its lowest and $3.65 at its peak.
People also own
Based on the portfolios of people who own PRTK. This list is generated using Robinhood data, and it’s not a recommendation.